Download your copy of the report today to explore the factors that lead to treatment discontinuation, as well as how oncologists rank currently available ALK+ NSCLC treatments, so you can help your brand stand out.
OptimizeRx Corporation (NASDAQ: OPRX) is the best-in-class health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. Connecting over 60% of U.S. healthcare providers and millions of their patients through a proprietary point-of-care network, connectivity is facilitated via its integrated Therapy Initiation and Persistence Platform. This powerful digital healthcare solutions platform is transforming market and patient access with the life sciences market by unlocking:
OptimizeRx Corporation
+1 (248) 651-6568